Fraser brings investment and board experience as a director at Equity Gap and non-executive director at Angel Capital Scotland. His background also includes business development roles in lending and enterprise support across Scottish chambers of commerce.
Equity Gap led the seed financing for the Edinburgh based manufacturer of custom fit respirators, with backing from Scottish Enterprise, Old College Capital, and Apollo Informal Investment.
"We realised that by combining modern 3D imaging with 3D-printed soft materials, we could create bespoke, perfectly fitted masks that conform to the unique contours of each face. In our first comparative trial, our masks proved more comfortable than standard disposable alternatives. Since then, we’ve refined our design dramatically yet we’ve remained true to our original mission: to create the most comfortable, personalised respiratory masks possible, suited for every face. We believe the days of painful, pressure-inducing masks are finally over."
The funding round was led by Equity Gap with co-investment from Scottish Enterprise and support from Lifted Ventures.
"Lifted Ventures immediately understood the challenges our product addresses for women and recognized the potential of the market we’re targeting. Their members are more than investors – they bring invaluable networks and skillsets that are often difficult to secure. I’ve been hugely impressed by their enthusiasm, capability, and commitment, especially in encouraging more female investors into equity investing."
Guinness Ventures led the round, with additional backing from Scottish Enterprise, Growthdeck, The SideBySide Partnership, Equity Gap, and Virgin Money.
"This investment accelerates our mission to deliver game improvement technology to 60 million golfers around the world. Throughout 2024 we plan to invest in infrastructure across the USA to support our retail and distribution partners. Golfers globally love our GPS, rangefinder and shot-tracking technology, having sold products in 160 different countries worldwide in 2023. Golf has experienced a huge change in the past 5 years, people of all ages and demographics love the sport. With Shot Scope golfers can improve quickly and enjoy the game they love even more."
Guinness Ventures led the Series B round alongside participants including Scottish Enterprise, Growthdeck, and Virgin Money.
"This investment accelerates our mission to delivergame improvement technology to 60 million golfers around the world. Throughout 2024 we plan to invest in infrastructure across the USA to support our retail and distribution partners. Golfers globally love our GPS, rangefinder and shot tracking technology, having sold products in 160 different countries worldwide in 2023. Golf has experienced a huge change in the past 5 years, people of all ages and demographics love the sport. With Shot Scope golfers can improve quickly and enjoy the game they love even more."
NovaQuest led the financing round, which drew participation from eight investors across three continents.
"Following on from our successful seed funding round from Gabriel Investments and Equity Gap, Series A is an important milestone in our global growth plans, as we seek to improve health outcomes for animals through earlier disease diagnosis using revolutionary biomarker technology and artificial intelligence. The geographical spread of this investment round reflects the global opportunity for MI:RNA to deploy our platform for better outcomes for pets."
